Shareholder Alert: Ademi LLP investigates whether Smartsheet Inc. has obtained a Fair Price for its Public Shareholders
Shareholder Alert: Ademi LLP investigates whether Smartsheet Inc. has obtained a Fair Price for its Public Shareholders
Ademi LLP is investigating Smartsheet (NYSE: SMAR) for possible breaches of fiduciary duty and other violations of law in its transaction with Blackstone and Vista.
Click here to learn how to join our investigation https://www.ademilaw.com/case/smartsheet-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
In the transaction, Smartsheet shareholders will receive only $56.50 per share in cash. The transaction agreement unreasonably limits competing transactions for Smartsheet by imposing a significant penalty if Smartsheet accepts a competing bid. Smartsheet insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of Smartsheet’s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
If you own Smartsheet common stock and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or https://www.ademilaw.com/case/smartsheet-inc.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
View source version on businesswire.com: https://www.businesswire.com/news/home/20240924495338/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks